Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stage

Seminars in Cancer Biology

Volumn 21, Issue 4, 2011, Pages 276-282

  Mohlin, Sofie A ^a   Wigerup, Caroline ^a   Påhlman, Sven ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Differentiation; Hypoxia; Neuroblastoma; Sympathetic nervous system; Tumor stem cells

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DOPAMINE BETA MONOOXYGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; NEU DIFFERENTIATION FACTOR; NEUROMODULIN; NEUROTROPHIN 3 RECEPTOR; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE P60; PROTEIN P300; PROTEIN TYROSINE KINASE A; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR MASH1; TYROSINE 3 MONOOXYGENASE; VASCULOTROPIN; VIMENTIN; WNT PROTEIN;

ADRENERGIC SYSTEM; CANCER STAGING; CELL FATE; CELL SURVIVAL; EMBRYO DEVELOPMENT; GENE EXPRESSION; HUMAN; HYPOXIA; MYCN GENE; NERVE CELL DIFFERENTIATION; NEURAL CREST; NEUROBLASTOMA; ONCOGENE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STEM CELL; SYMPATHETIC NERVE CELL; UPREGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; CHILD; HUMANS; NEOPLASM STAGING; NEOPLASTIC STEM CELLS; NEUROBLASTOMA; NEURONS;

EID: 80655146975     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2011.09.002     Document Type: Review

References (102)

1. Cushing H., Wolbach S.B. The transformation of a malignant paravertebral sympathicoblastoma into a benign ganglioneuroma. Am J Pathol 1927, 3(May (3)):203-216.
2. Odelstad L., Påhlman S., Nilsson K., Larsson E., Läckgren G., Johansson K.E., et al. Neuron-specific enolase in relation to differentiation in human neuroblastoma. Brain Res 1981, 224(November (1)):69-82.
3. Hoehner J.C., Gestblom C., Hedborg F., Sandstedt B., Olsen L., Påhlman S. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage. Lab Invest 1996, 75(November (5)):659-675.
4. LaBrosse E.H., Comoy E., Bohuon C., Zucker J.M., Schweisguth O. Catecholamine metabolism in neuroblastoma. J Natl Cancer Inst 1976, 57(September (3)):633-638.
5. Påhlman S., Odelstad L., Larsson E., Grotte G., Nilsson K. Phenotypic changes of human neuroblastoma cells in culture induced by 12-O-tetradecanoyl-phorbol-13-acetate. Int J Cancer 1981, 28(November (5)):583-589.
6. Påhlman S., Ruusala A.I., Abrahamsson L., Mattsson M.E., Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 1984, 14(June (2)):135-144.
7. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982, 68(April (4)):589-596.
8. Edsjö A., Holmquist L., Påhlman S. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol 2007, 17(June (3)):248-256.
9. Anderson D.J. Cellular and molecular biology of neural crest cell lineage determination. Trends Genet 1997, 13(July (7)):276-280.
10. Le Douarin N.M. The neural crest 1982, Cambridge University Press, Cambridge.
11. Henion P.D., Weston J.A. Timing and pattern of cell fate restrictions in the neural crest lineage. Development 1997, 124(November (21)):4351-4359.
12. Duff R.S., Langtimm C.J., Richardson M.K., Sieber-Blum M. In vitro clonal analysis of progenitor cell patterns in dorsal root and sympathetic ganglia of the quail embryo. Dev Biol 1991, 147(October (2)):451-459.
13. Hagedorn L., Suter U., Sommer L. P0 and PMP22 mark a multipotent neural crest-derived cell type that displays community effects in response to TGF-beta family factors. Development 1999, 126(September (17)):3781-3794.
14. Li H.Y., Say E.H., Zhou X.F. Isolation and characterization of neural crest progenitors from adult dorsal root ganglia. Stem Cells 2007, 25(August (8)):2053-2065.
15. Sextier-Sainte-Claire Deville F., Ziller C., Le Douarin N. Developmental potentialities of cells derived from the truncal neural crest in clonal cultures. Brain Res Dev Brain Res 1992, 66(March (1)):1-10.
16. Sextier-Sainte-Claire Deville F., Ziller C., Le Douarin N.M. Developmental potentials of enteric neural crest-derived cells in clonal and mass cultures. Dev Biol 1994, 163(May (1)):141-151.
17. Bondurand N., Natarajan D., Thapar N., Atkins C., Pachnis V. Neuron and glia generating progenitors of the mammalian enteric nervous system isolated from foetal and postnatal gut cultures. Development 2003, 130(December (25)):6387-6400.
18. Kruger G.M., Mosher J.T., Bixby S., Joseph N., Iwashita T., Morrison S.J. Neural crest stem cells persist in the adult gut but undergo changes in self-renewal, neuronal subtype potential, and factor responsiveness. Neuron 2002, 35(August (4)):657-669.
19. Morrison S.J., White P.M., Zock C., Anderson D.J. Prospective identification, isolation by flow cytometry, and in vivo self-renewal of multipotent mammalian neural crest stem cells. Cell 1999, 96(March (5)):737-749.
20. Anderson D.J., Axel R. A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell 1986, 47(December (6)):1079-1090.
21. Anderson D.J., Carnahan J.F., Michelsohn A., Patterson P.H. Antibody markers identify a common progenitor to sympathetic neurons and chromaffin cells in vivo and reveal the timing of commitment to neuronal differentiation in the sympathoadrenal lineage. J Neurosci 1991, 11(November (11)):3507-3519.
22. Shah N.M., Groves A.K., Anderson D.J. Alternative neural crest cell fates are instructively promoted by TGFbeta superfamily members. Cell 1996, 85(May (3)):331-343.
23. Bitgood M.J., McMahon A.P. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995, 172(November (1)):126-138.
24. Lahav R., Dupin E., Lecoin L., Glavieux C., Champeval D., Ziller C., et al. Endothelin 3 selectively promotes survival and proliferation of neural crest-derived glial and melanocytic precursors in vitro. Proc Natl Acad Sci U S A 1998, 95(November (24)):14214-14219.
25. Trentin A., Glavieux-Pardanaud C., Le Douarin N.M., Dupin E. Self-renewal capacity is a widespread property of various types of neural crest precursor cells. Proc Natl Acad Sci U S A 2004, 101(March (13)):4495-4500.
26. Liu H., Margiotta J.F., Howard M.J. BMP4 supports noradrenergic differentiation by a PKA-dependent mechanism. Dev Biol 2005, 286(October (2)):521-536.
27. Reissmann E., Ernsberger U., Francis-West P.H., Rueger D., Brickell P.M., Rohrer H. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 1996, 122(July (7)):2079-2088.
28. Zimmerman L.B., De Jesus-Escobar J.M., Harland R.M. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996, 86(August (4)):599-606.
29. Smith W.C., Harland R.M. Expression cloning of noggin, a new dorsalizing factor localized to the Spemann organizer in Xenopus embryos. Cell 1992, 70(September (5)):829-840.
30. Schneider C., Wicht H., Enderich J., Wegner M., Rohrer H. Bone morphogenetic proteins are required in vivo for the generation of sympathetic neurons. Neuron 1999, 24(December (4)):861-870.
31. Lo L., Sommer L., Anderson D.J. MASH1 maintains competence for BMP2-induced neuronal differentiation in post-migratory neural crest cells. Curr Biol 1997, 7(June (6)):440-450.
32. Lo L., Morin X., Brunet J.F., Anderson D.J. Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells. Neuron 1999, 22(April (4)):693-705.
33. Morin X., Cremer H., Hirsch M.R., Kapur R.P., Goridis C., Brunet J.F. Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 1997, 18(March (3)):411-423.
34. Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 1997, 124(October (20)):4065-4075.
35. Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 1999, 399(May (6734)):366-370.
36. Stanke M., Junghans D., Geissen M., Goridis C., Ernsberger U., Rohrer H. The Phox2 homeodomain proteins are sufficient to promote the development of sympathetic neurons. Development 1999, 126(September (18)):4087-4094.
37. Guillemot F., Lo L.C., Johnson J.E., Auerbach A., Anderson D.J., Joyner A.L. Mammalian achaete-scute homolog 1 is required for the early development of olfactory and autonomic neurons. Cell 1993, 75(November (3)):463-476.
38. Hirsch M.R., Tiveron M.C., Guillemot F., Brunet J.F., Goridis C. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 1998, 125(February (4)):599-608.
39. Lo L., Tiveron M.C., Anderson D.J. MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. Development 1998, 125(February (4)):609-620.
40. Howard M., Foster D.N., Cserjesi P. Expression of HAND gene products may be sufficient for the differentiation of avian neural crest-derived cells into catecholaminergic neurons in culture. Dev Biol 1999, 215(November (1)):62-77.
41. Howard M.J., Stanke M., Schneider C., Wu X., Rohrer H. The transcription factor dHAND is a downstream effector of BMPs in sympathetic neuron specification. Development 2000, 127(September (18)):4073-4081.
42. Amiel J., Laudier B., Attie-Bitach T., Trang H., de Pontual L., Gener B., et al. Polyalanine expansion and frameshift mutations of the paired-like homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 2003, 33(April (4)):459-461.
43. Rohrer T., Trachsel D., Engelcke G., Hammer J. Congenital central hypoventilation syndrome associated with Hirschsprung's disease and neuroblastoma: case of multiple neurocristopathies. Pediatr Pulmonol 2002, 33(January (1)):71-76.
44. Trochet D., Bourdeaut F., Janoueix-Lerosey I., Deville A., de Pontual L., Schleiermacher G., et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet 2004, 74(April (4)):761-764.
45. Bourdeaut F., Trochet D., Janoueix-Lerosey I., Ribeiro A., Deville A., Coz C., et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Cancer Lett 2005, 228(October (1-2)):51-58.
46. Mosse Y.P., Laudenslager M., Khazi D., Carlisle A.J., Winter C.L., Rappaport E., et al. Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet 2004, 75(October (4)):727-730.
47. van Limpt V., Schramm A., van Lakeman A., Sluis P., Chan A., van Noesel M., et al. The Phox2B homeobox gene is mutated in sporadic neuroblastomas. Oncogene 2004, 23(December (57)):9280-9288.
48. Massari M.E., Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000, 20(January (2)):429-440.
49. Bertrand N., Castro D.S., Guillemot F. Proneural genes and the specification of neural cell types. Nat Rev Neurosci 2002, 3(July (7)):517-530.
50. Gestblom C., Grynfeld A., Øra I., Ortoft E., Larsson C., Axelson H., et al. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas. Lab Invest 1999, 79(January (1)):67-79.
51. Breit S., Schwab M. Suppression of MYC by high expression of NMYC in human neuroblastoma cells. J Neurosci Res 1989, 24(September (1)):21-28.
52. Sawai S., Shimono A., Wakamatsu Y., Palmes C., Hanaoka K., Kondoh H. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 1993, 117(April (4)):1445-1455.
53. Birren S.J., Lo L., Anderson D.J. Sympathetic neuroblasts undergo a developmental switch in trophic dependence. Development 1993, 119(November (3)):597-610.
54. Verdi J.M., Groves A.K., Farinas I., Jones K., Marchionni M.A., Reichardt L.F., et al. A reciprocal cell-cell interaction mediated by NT-3 and neuregulins controls the early survival and development of sympathetic neuroblasts. Neuron 1996, 16(March (3)):515-527.
55. Hoehner J.C., Olsen L., Sandstedt B., Kaplan D.R., Påhlman S. Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am J Pathol 1995, 147(July (1)):102-113.
56. Nakagawara A., Arima-Nakagawara M., Scavarda N.J., Azar C.G., Cantor A.B., Brodeur G.M. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma. N Engl J Med 1993, 328(March (12)):847-854.
57. Yamashiro D.J., Nakagawara A., Ikegaki N., Liu X.G., Brodeur G.M. Expression of TrkC in favorable human neuroblastomas. Oncogene 1996, 12(January (1)):37-41.
58. Påhlman S., Hoehner J.C. Neurotrophin receptors, tumor progression and tumor maturation. Mol Med Today 1996, 2(October (10)):432-438.
59. Bjelfman C., Hedborg F., Johansson I., Nordenskjöld M., Påhlman S. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis. Cancer Res 1990, 50(November (21)):6908-6914.
60. Hedborg F., Ohlsson R., Sandstedt B., Grimelius L., Hoehner J.C., Påhlman S. IGF2 expression is a marker for paraganglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 1995, 146(April (4)):833-847.
61. Oberthuer A., Berthold F., Warnat P., Hero B., Kahlert Y., Spitz R., et al. Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification. J Clin Oncol 2006, 24(November (31)):5070-5078.
62. Wang Q., Diskin S., Rappaport E., Attiyeh E., Mosse Y., Shue D., et al. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res 2006, 66(June (12)):6050-6062.
63. Fredlund E., Ringner M., Maris J.M., Påhlman S. High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma. Proc Natl Acad Sci U S A 2008, 105(September (37)):14094-14099.
64. Holmquist-Mengelbier L., Fredlund E., Löfstedt T., Noguera R., Navarro S., Nilsson H., et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 2006, 10(November (5)):413-423.
65. Makino Y., Cao R., Svensson K., Bertilsson G., Asman M., Tanaka H., et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 2001, 414(November (6863)):550-554.
66. Maynard M.A., Evans A.J., Shi W., Kim W.Y., Liu F.F., Ohh M. Dominant-negative HIF-3 alpha 4 suppresses VHL-null renal cell carcinoma progression. Cell Cycle 2007, 6(November (22)):2810-2816.
67. Gestblom C., Hoehner J.C., Hedborg F., Sandstedt B., Påhlman S. In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas. Am J Pathol 1997, 150(January (1)):107-117.
68. Jögi A., Øra I., Nilsson H., Lindeheim A., Makino Y., Poellinger L., et al. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci U S A 2002, 99(May (10)):7021-7026.
69. Jögi A., Vallon-Christersson J., Holmquist L., Axelson H., Borg A., Påhlman S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp Cell Res 2004, 295(May (2)):469-487.
70. Fredlund E., Ovenberger M., Borg K., Påhlman S. Transcriptional adaptation of neuroblastoma cells to hypoxia. Biochem Biophys Res Commun 2008, 366(February (4)):1054-1060.
71. Hedborg F., Ulleras E., Grimelius L., Wassberg E., Maxwell P.H., Hero B., et al. Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma. FASEB J 2003, 17(April (6)):598-609.
72. Hedborg F., Fischer-Colbrie R., Ostlin N., Sandstedt B., Tran M.G., Maxwell P.H. Differentiation in neuroblastoma: diffusion-limited hypoxia induces neuro-endocrine secretory protein 55 and other markers of a chromaffin phenotype. PLoS One 2010, 5(9).
73. Helczynska K., Kronblad A., Jögi A., Nilsson E., Beckman S., Landberg G., et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003, 63(April (7)):1441-1444.
74. Heddleston J.M., Li Z., McLendon R.E., Hjelmeland A.B., Rich J.N. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009, 8(October (20)):3274-3284.
75. Yeung T.M., Gandhi S.C., Bodmer W.F. Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci U S A 2011, 108(March (11)):4382-4387.
76. Ghafar M.A., Anastasiadis A.G., Chen M.W., Burchardt M., Olsson L.E., Xie H., et al. Acute hypoxia increases the aggressive characteristics and survival properties of prostate cancer cells. Prostate 2003, 54(January (1)):58-67.
77. Ezashi T., Das P., Roberts R.M. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A 2005, 102(March (13)):4783-4788.
78. Tsai C.C., Chen Y.J., Yew T.L., Chen L.L., Wang J.Y., Chiu C.H., et al. Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood 2011, 117(January (2)):459-469.
79. Yoshida Y., Takahashi K., Okita K., Ichisaka T., Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009, 5(September (3)):237-241.
80. Morrison S.J., Csete M., Groves A.K., Melega W., Wold B., Anderson D.J. Culture in reduced levels of oxygen promotes clonogenic sympathoadrenal differentiation by isolated neural crest stem cells. J Neurosci 2000, 20(October (19)):7370-7376.
81. Studer L., Csete M., Lee S.H., Kabbani N., Walikonis J., Wold B., et al. Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 2000, 20(October (19)):7377-7383.
82. Horie N., So K., Moriya T., Kitagawa N., Tsutsumi K., Nagata I., et al. Effects of oxygen concentration on the proliferation and differentiation of mouse neural stem cells in vitro. Cell Mol Neurobiol 2008, 28(September (6)):833-845.
83. Santilli G., Lamorte G., Carlessi L., Ferrari D., Rota Nodari L., Binda E., et al. Mild hypoxia enhances proliferation and multipotency of human neural stem cells. PLoS One 2010, 5(1):e8575.
84. Giese A.K., Frahm J., Hubner R., Luo J., Wree A., Frech M.J., et al. Erythropoietin and the effect of oxygen during proliferation and differentiation of human neural progenitor cells. BMC Cell Biol 2010, 11:94.
85. Milosevic J., Schwarz S.C., Krohn K., Poppe M., Storch A., Schwarz J. Low atmospheric oxygen avoids maturation, senescence and cell death of murine mesencephalic neural precursors. J Neurochem 2005, 92(February (4)):718-729.
86. Pistollato F., Chen H.L., Schwartz P.H., Basso G., Panchision D.M. Oxygen tension controls the expansion of human CNS precursors and the generation of astrocytes and oligodendrocytes. Mol Cell Neurosci 2007, 35(July (3)):424-435.
87. Chow D.C., Wenning L.A., Miller W.M., Papoutsakis E.T. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 2001, 81(August (2)):685-696.
88. Parmar K., Mauch P., Vergilio J.A., Sackstein R., Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 2007, 104(March (13)):5431-5436.
89. Kiel M.J., Morrison S.J. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 2008, 8(April (4)):290-301.
90. Sugiyama T., Kohara H., Noda M., Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006, 25(December (6)):977-988.
91. Tavazoie M., Van der Veken L., Silva-Vargas V., Louissaint M., Colonna L., Zaidi B., et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell 2008, 3(September (3)):279-288.
92. Tang W., Zeve D., Suh J.M., Bosnakovski D., Kyba M., Hammer R.E., et al. White fat progenitor cells reside in the adipose vasculature. Science 2008, 322(October (5901)):583-586.
93. Pietras A., Gisselsson D., Øra I., Noguera R., Beckman S., Navarro S., et al. High levels of HIF-2alpha highlight an immature neural crest-like neuroblastoma cell cohort located in a perivascular niche. J Pathol 2008, 214(March (4)):482-488.
94. Noguera R., Fredlund E., Piqueras M., Pietras A., Beckman S., Navarro S., et al. HIF-1alpha and HIF-2alpha are differentially regulated in vivo in neuroblastoma: high HIF-1alpha correlates negatively to advanced clinical stage and tumor vascularization. Clin Cancer Res 2009, 15(December (23)):7130-7136.
95. Calabrese C., Poppleton H., Kocak M., Hogg T.L., Fuller C., Hamner B., et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007, 11(January (1)):69-82.
96. Bao S., Wu Q., Sathornsumetee S., Hao Y., Li Z., Hjelmeland A.B., et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006, 66(August (16)):7843-7848.
97. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15(June (6)):501-513.
98. Seidel S., Garvalov B.K., Wirta V., von Stechow L., Schanzer A., Meletis K., et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 2010, 133(April (Pt 4)):983-995.
99. Tian H., Hammer R.E., Matsumoto A.M., Russell D.W., McKnight S.L. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998, 12(November (21)):3320-3324.
100. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3(October (10)):721-732.
101. Löfstedt T., Jögi A., Sigvardsson M., Gradin K., Poellinger L., Påhlman S., et al. Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 2004, 279(September (38)):39223-39231.
102. Gustafsson M.V., Zheng X., Pereira T., Gradin K., Jin S., Lundkvist J., et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005, 9(November (5)):617-628.